Particular interaction between efavirenz and the HIV-1 reverse transcriptase binding site as explained by the ONIOM2 method

被引：23
|
作者：
Nunrium, P
Kuno, M
Saen-Oon, S
Hannongbua, S
机构：
[1] Kasetsart Univ, Fac Sci, Dept Chem, Bangkok 10900, Thailand
[2] Srinakharinwirot Univ, Dept Chem, Bangkok 10330, Thailand
[3] Chulalongkorn Univ, Dept Chem, Computat Chem Unit Cell, Bangkok 10330, Thailand
来源：
CHEMICAL PHYSICS LETTERS | 2005年 / 405卷 / 1-3期
关键词：
D O I：
10.1016/j.cplett.2005.02.023
中图分类号：
O64 [物理化学（理论化学）、化学物理学];
学科分类号：
070304 ; 081704 ;
摘要：
Particular interaction between efavirenz and the HIV-1 reverse transcriptase binding site was investigated, based on the B3LYP/ 6-31G(d,p) and ONIOM2 methods. The interaction between efavirenz and Lys101 was found to be the strongest interaction, typically, -11.29 kcal/mol. The stability of this complex system leads to the foundation of the estimated binding energy of approximately -22.66 kcal/mol. Moreover, two hydrogen bonds between benzoxazin-2-one, and the backbone carbonyl oxygen and the backbone amino hydrogen of Lys101 were observed. These hydrogen bond interactions play an important role in the bound efavirenz/HIV-1 RT complex. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码：198 / 202
页数：5
相关论文
共 50 条
  • [1] Theoretical investigation on nevirapine and HIV-1 reverse transcriptase binding site interaction, based on ONIOM method
    Kuno, M
    Hannongbua, S
    Morokuma, K
    CHEMICAL PHYSICS LETTERS, 2003, 380 (3-4) : 456 - 463
  • [2] Efavirenz Binding Site in HIV-1 Reverse Transcriptase Monomers
    Braz, Valerie A.
    Barkley, Mary D.
    Jockusch, Rebecca A.
    Wintrode, Patrick L.
    BIOCHEMISTRY, 2010, 49 (49) : 10565 - 10573
  • [3] Key interactions of the mutant HIV-1 reverse transcriptase/efavirenz: an evidence obtained from ONIOM method
    Boonsri, Pornthip
    Kuno, Mayuso
    Hannongbua, Supa
    MEDCHEMCOMM, 2011, 2 (12) : 1181 - 1187
  • [4] Efavirenz alters the interaction between HIV-1 reverse transcriptase and template/primer
    Radzio, J.
    Sheen, C.-W.
    Sluis-Cremer, N.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S133 - S133
  • [5] Efavirenz alters the interaction between HIV-1 reverse transcriptase and template/primer
    Radizio, J.
    Sheen, C-W
    Sluis-Cremer, N.
    ANTIVIRAL THERAPY, 2007, 12 : S133 - S133
  • [6] Efavirenz Binding to HIV-1 Reverse Transcriptase Monomers and Dimers
    Braz, Valerie A.
    Holladay, Leslie A.
    Barkley, Mary D.
    BIOCHEMISTRY, 2010, 49 (03) : 601 - 610
  • [7] Effects of efavirenz binding on the subunit equilibria of HIV-1 reverse transcriptase
    Venezia, CF
    Howard, KJ
    Ignatov, ME
    Holladay, LA
    Barkley, MD
    BIOCHEMISTRY, 2006, 45 (09) : 2779 - 2789
  • [8] Molecular mechanics PBSA ligand binding energy and interaction of Efavirenz derivatives with HIV-1 reverse transcriptase
    Weinzinger, P
    Hannongbua, S
    Wolschann, P
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2005, 20 (02) : 129 - 134
  • [9] Molecular Origins of HIV-1 reverse Transcriptase Resistance to Efavirenz
    Deredge, Daniel J.
    Howard, Kathryn J.
    Seckler, James M.
    Barkley, Mary D.
    Wintrode, Patrick L.
    BIOPHYSICAL JOURNAL, 2011, 100 (03) : 227 - 227
  • [10] A biochemical look into the nucleotide binding site of HIV-1 reverse transcriptase
    Menéndez-Arias, L
    Cases-González, CE
    Gutiérrez-Rivas, M
    FIFTH EUROPEAN CONFERENCE ON EXPERIMENTAL AIDS RESEARCH (ECEAR 2000), 2000, : 1 - 9
12345